These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Drop metastasis from hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. Lee SK, Song MJ. Korean J Intern Med; 2017 Sep; 32(5):943-944. PubMed ID: 27608971 [No Abstract] [Full Text] [Related]
25. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure? Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G. Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300 [Abstract] [Full Text] [Related]
26. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho KC, Contractor D, Korogodsky M. J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410 [Abstract] [Full Text] [Related]
27. Factors in successful radiofrequency ablation therapy for malignant liver tumors. Sakakima Y, Inoue S, Takeda S, Kaneko T, Nakao A. Hepatogastroenterology; 2004 Nov; 51(60):1761-5. PubMed ID: 15532821 [Abstract] [Full Text] [Related]
28. Complications arising from radiofrequency ablation of hepatocellular carcinoma and preventative measure. Huang JS, Ma KS. Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):248-50. PubMed ID: 22988549 [No Abstract] [Full Text] [Related]
29. Radiofrequency ablation of hepatocellular carcinoma: who should do it? Belghiti J, Vilgrain V. Ann Surg Oncol; 2005 Aug; 12(8):579-80. PubMed ID: 16021532 [No Abstract] [Full Text] [Related]
30. Radiofrequency ablation for the management of liver tumors. Bachar GN, Greif F, Mor E, Tur-Kaspa R, Belenky A. Isr Med Assoc J; 2003 Jul; 5(7):496-500. PubMed ID: 12901246 [Abstract] [Full Text] [Related]
31. MR-guided ablation of hepatocellular carcinoma aided by gadoxetic acid. Bathe OF, Mahallati H. J Surg Oncol; 2007 Jun 15; 95(8):670-3. PubMed ID: 17345591 [Abstract] [Full Text] [Related]
32. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow: comparison with standard percutaneous radiofrequency ablation therapy. Rhim H. Cancer; 2003 Jul 15; 98(2):433-4; author reply 434-5. PubMed ID: 12872368 [No Abstract] [Full Text] [Related]
33. Secondary hemocholecyst after radiofrequency ablation therapy for hepatocellular carcinoma. Yamamoto T, Kubo S, Hirohashi K, Tanaka S, Uenishi T, Ogawa M, Sakabe K, Hai S, Yamamoto S, Shuto T, Tanaka H, Kinoshita H. J Gastroenterol; 2003 Jul 15; 38(4):399-403. PubMed ID: 12743783 [Abstract] [Full Text] [Related]